PHARMA - Relationships

Word 1 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 1 Count Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	CAT1 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	CAT2 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 2 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 2 Count Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Co-occurrence Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Occurence-Centile Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Correlation Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Overlap-Metric Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	G-Metric Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►
Lung Cancer		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Cancer		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Arrhythmia		Disease	Drug	Apresoline (Hydralazine)- FDA
Carcinoma		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Carcinoma		Disease	Target	4-1BB Receptor
Cancer		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Stroke		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Scars		Disease	Drug	Dracorhodin
Collagen		Target	Drug	Ascorbic Acid (Vitamin C)- FDA
Cancer		Disease	Target	BRSK1
Cholesterol		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Anemia		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Cancer		Disease	Target	4-1BB Receptor
Glomerulonephritis		Disease	Drug	Apresoline (Hydralazine)- FDA
Breast Cancer		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Prostate Cancer		Disease	Drug	Dracorhodin
Cancer		Disease	Drug	Dracorhodin
Angiotensin Converting Enzyme		Target	Drug	Apresoline (Hydralazine)- FDA
Myelodysplastic Syndrome		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Infection		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Hepatitis		Disease	Drug	Apresoline (Hydralazine)- FDA
Diabetic Nephropathy		Disease	Drug	Dracorhodin
Renal Failure		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Psychiatric Disorder		Disease	Target	Cyclooxygenase-3
Aldosterone Receptor		Target	Drug	Apresoline (Hydralazine)- FDA
Graft Versus Host Disease		Disease	Target	4-1BB Receptor
Syphilis		Disease	Drug	Apresoline (Hydralazine)- FDA
Lung Cancer		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
APOE		Target	Target	BRSK1
Anemia		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
CD4		Target	Target	4-1BB Receptor
Azacitidine (Vidaza)- FDA		Drug	Drug	Aranesp (Darbepoetin Alfa)- FDA
Acute Promyelocytic Leukemia		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Carcinoma		Disease	Target	BRSK1
Diabetes		Disease	Target	BRSK1
Calmodulin		Target	Target	BRSK1
Obesity		Disease	Target	BRSK1
CD68		Target	Target	Eotaxin-2/CCL24
Cancer		Disease	Drug	Aralen (Chloroquine)- FDA
Anemia		Disease	Target	ALK Phos
Benign Prostatic Hyperplasia		Disease	Target	Kallikrein-8
Eotaxin		Target	Target	464.1
Infection		Disease	Target	Tegument Protein Vp16
Cancer		Disease	Target	Kallikrein-8
CD1A		Target	Target	AMAC-1
CCL4		Target	Target	Eotaxin-2/CCL24
Graft Versus Host Disease		Disease	Target	AMAC-1
Shock		Disease	Target	Tegument Protein Vp16
Carcinoma		Disease	Target	464.1
Atridox (Doxycycline Hyclate)- FDA		Drug	Drug	Aralen (Chloroquine)- FDA